Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
Hidradenitis Suppurativa: Guidelines and Pipelines
Course Overview
Preview what you'll learn in this program
What You'll Learn
A variety of clinical guidelines have recently been developed for the treatment of Hidradenitis Suppurativa. These guidelines appreciate the complexity of disease as well as a number of gaps in our knowledge regarding disease pathogenesis, disease heterogeneity, and predicting response to therapy.
Our knowledge regarding disease mechanisms and pathogenesis has increased dramatically over the past few years both with regards to clinical associations, disease triggers, genetics, and molecular pathophysiology of disease. These publications question our established treatment approaches and identify multiple novel targets for new therapies.
This course reviews both the existing therapeutic guidelines for HS along with emerging HS therapies, and also discusses how these novel therapies and new knowledge (such as genetics, treatment biomarkers, and new treatments) will shape our management of HS over the next 5 years.
Learning Objectives
- Describe the range of current treatment guidelines for HS
- Compare the emerging knowledge of HS pathogenesis with current therapeutic approaches
- Review the variety of novel pipeline treatments for HS currently under development
- Discuss the way in which these pipeline treatments may influence HS guidelines over the next 5 years
Faculty
Editors
Accreditation Information
A variety of clinical guidelines have recently been developed for the treatment of Hidradenitis Suppurativa. These guidelines appreciate the complexity of disease as well as a number of gaps in our knowledge regarding disease pathogenesis, disease heterogeneity, and predicting response to therapy.
Our knowledge regarding disease mechanisms and pathogenesis has increased dramatically over the past few years both with regards to clinical associations, disease triggers, genetics, and molecular pathophysiology of disease. These publications question our established treatment approaches and identify multiple novel targets for new therapies.
This course reviews both the existing therapeutic guidelines for HS along with emerging HS therapies, and also discusses how these novel therapies and new knowledge (such as genetics, treatment biomarkers, and new treatments) will shape our management of HS over the next 5 years.
Disclaimer
This website – LearnSkin by LearnHealth Inc. - and the information provided on the website is for educational purposes only. The information provided does not replace advice from a physician or a qualified health provider. The information provided on this website should never be used as a substitute for medical advice, diagnosis or treatment of health conditions or problems and should never be used to disregard, delay or refuse treatment. LearnHealth Inc. makes no warranties nor express or implied representations whatsoever regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced on this Website. LearnHealth Inc. does not assume any risk whatsoever for your use of this Website or the information contained herein. Health-related information changes frequently and therefore information contained on this Website may be outdated, incomplete or incorrect. Statements made about products are not official statements made by the Food and Drug Administration. Use of this Website does not create an expressed or implied physician-patient relationship. You are hereby advised to consult with a physician or other professional health care provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any health care problem or issue you might have at any time, now or in the future. In using this Website, you agree that neither LearnHealth Inc. nor any other party is or will be liable or otherwise be responsible for any decision made or any action taken or any action not taken due to your use of any information presented.
✨ Ready to Begin Your Journey? ✨
Enroll now to start the course and unlock all learning materials
Hidradenitis Suppurativa: Guidelines and Pipelines Module
Complete the previous section to unlock this lesson
Course Discussion
Join the conversation with fellow learners
Also Recommended
Hidradenitis Suppurativa: Case Based Management
Managing Pain in a Patient with Hidradenitis Suppurativa
Clinical Approach to Hidradenitis Suppurativa and Emerging Therapies
Understanding Aspects of Shared Decision Making in a Patient with Hidradenitis Suppurativa
